MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the 'Company' or 'MindMed'), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today...